Adoptive cell therapy based on ex-vivo expanded tumor-infiltrating lymphocytes (TILs) has historically been most effective in ...

Abatacept is a disease-modifying antirheumatic drug (DMARD) used in the management of rheumatic conditions, such as ...

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited tumor-infiltrating lymphocytes (TILs) may be ...

A WOMAN who was told she had a nasty chest infection after suffering from a persistent cough discovered it was actually a ...

SunAct Advanced Cancer Therapies launches third advanced oncology centre at Dr. Gupte Hospital, Khar, Mumbai: Our Bureau, ...

A new study reveals the C-reactive protein-albumin-lymphocyte (CALLY) index is a strong predictor of long-term survival in ...

Neoadjuvant PD-1 blockade in early-stage mismatch repair–deficient solid rectal and non-rectal tumors can eliminate the need ...

A new meta-analysis shows point-of-care testing reduces unnecessary antibiotics in patients experiencing COPD exacerbations, ...

With the business potentially at an important milestone, we thought we'd take a closer look at Iovance Biotherapeutics, Inc.'s (NASDAQ:IOVA) future prospects. Iovance Biotherapeutics, Inc., a ...

The American Association for Cancer Research’s annual conference featured updates from several companies on key candidates ...